Gut microbial fatty acid metabolites (KetoA and KetoC) affect the progression of nonalcoholic steatohepatitis and reverse cholesterol transport metabolism in mouse model. Issue 2 (10th February 2020)

• Record Type: Journal Article
• Authors: Sofyana, Neng Tanty; Zheng, Jiawen; Manabe, Yuki; Yamamoto, Yuta; Kishino, Shigenobu; Ogawa, Jun; Sugawara, Tatsuya
• Is Part Of: Lipids. Volume 55:Issue 2(2020)
• Page Start: 151
• Page End: 162
• Publication Date: 2020-02-10
• Subjects: Gut microorganism -- Lactic acid bacterium -- Nonalcoholic steatohepatitis -- Oxo fatty acids -- Polyunsaturated fatty acids; Lipids -- Periodicals; Lipids -- Periodicals; Lipiden; Lipides -- Périodiques; 547.77
• DOI: 10.1002/lipd.12219
• Languages: English
• ISSNs: 0024-4201

Abstract

Abstract: Nonalcoholic steatohepatitis (NASH) is a common liver disease that occurs in both alcoholics and nonalcoholics. Oxidative stress is a possible causative factor for liver diseases including NASH. Gut microorganisms, especially lactic acid bacteria, can produce unique fatty acids, including hydroxy, oxo, conjugated, and partially saturated fatty acids. The oxo fatty acid 10‐oxo‐11( E )‐octadecenoic acid (KetoC) provides potent cytoprotective effects against oxidative stress through activation of Nrf2‐ARE pathway. The aim of this study was to explore the preventive and therapeutic effects of gut microbial fatty acid metabolites in a NASH mouse model. The mice were divided into 3 experimental groups and fed as follows: (1) high‐fat diet (HFD) (2) HFD mixed with 0.1% KetoA (10‐oxo‐12( Z )‐octadecenoic acid), and (3) HFD mixed with 0.1% KetoC. After 3 weeks of feeding, plasma parameters, liver histology, and mRNA expression of multiple genes were assessed. There was hardly any difference in fat accumulation in the histological study; however, no ballooning occurred in 2/5 mice of KetoC group. Bridging fibrosis was not observed in the KetoA group, although KetoA administration did not significantly suppress fibrosis score ( p = 0.10). In addition, KetoC increased the expression level of HDL related genes and HDL cholesterol levels in the plasma. These results indicated that KetoA and KetoC may partly affect the progression of NASH in mice models.